Literature DB >> 16761625

Oncology of companion animals as a model for humans. an overview of tumor histotypes.

A Porrello1, P Cardelli, E P Spugnini.   

Abstract

The need for more appropriate animal models in cancer research has led, over the past 20 years, to consider pets with spontaneously occurring neoplasms as a valuable and still under used resource. The role of companion animals in the struggle to eradicate cancer can be multiple: they may act as environmental sentinels, help in gaining insights on tumor biology and finally may be enrolled in therapeutic trials which might act as a bridge to the clinic applications. This paper will focus on the most valuable spontaneous neoplasms in companion animals and will analyze the potentials of each histotype as a model for basic research and for new therapeutic strategies. It is conceivable that in the next years comparative oncology will play a paramount role in translational medicine allowing a rapid flow of data from laboratories to clinical application in humans.

Entities:  

Mesh:

Year:  2006        PMID: 16761625

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  35 in total

1.  The many challenges of veterinary oncology.

Authors:  Camilla Kidd
Journal:  Can Vet J       Date:  2008-11       Impact factor: 1.008

2.  Canine malignant melanoma alpha-3 integrin binding peptides.

Authors:  Olulanu H Aina; Yoshiko Maeda; Matthew Harrison; Allison L Zwingenberger; Naomi J Walker; Kit S Lam; Michael S Kent
Journal:  Vet Immunol Immunopathol       Date:  2011-05-19       Impact factor: 2.046

3.  Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs.

Authors:  Jessian L Munoz; Steven J Greco; Shyam A Patel; Lauren S Sherman; Suresh Bhatt; Rekha S Bhatt; Jeffrey A Shrensel; Yan-Zhong Guan; Guiqin Xie; Jiang-Hong Ye; Pranela Rameshwar; Allan Siegel
Journal:  Differentiation       Date:  2012-07-21       Impact factor: 3.880

4.  Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer.

Authors:  R K DeLong; Yi-Hsien Cheng; Paige Pearson; Zhoumeng Lin; Calli Coffee; Elza Neelima Mathew; Amanda Hoffman; Raelene M Wouda; Mary Lynn Higginbotham
Journal:  J Pharmacol Exp Ther       Date:  2019-04-30       Impact factor: 4.030

Review 5.  Modeling opportunities in comparative oncology for drug development.

Authors:  Ira K Gordon; Chand Khanna
Journal:  ILAR J       Date:  2010

Review 6.  Comparative oncology today.

Authors:  Melissa C Paoloni; Chand Khanna
Journal:  Vet Clin North Am Small Anim Pract       Date:  2007-11       Impact factor: 2.093

7.  Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.

Authors:  Giovanni P Burrai; Sulma I Mohammed; Margaret A Miller; Vincenzo Marras; Salvatore Pirino; Maria F Addis; Sergio Uzzau; Elisabetta Antuofermo
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

8.  A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo.

Authors:  Erin E Thacker; Masaharu Nakayama; Bruce F Smith; R Curtis Bird; Zhanat Muminova; Theresa V Strong; Laura Timares; Nikolay Korokhov; Ann Marie O'Neill; Tanja D de Gruijl; Joel N Glasgow; Kenzaburo Tani; David T Curiel
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

9.  Comparative expression pathway analysis of human and canine mammary tumors.

Authors:  Paolo Uva; Luigi Aurisicchio; James Watters; Andrey Loboda; Amit Kulkarni; John Castle; Fabio Palombo; Valentina Viti; Giuseppe Mesiti; Valentina Zappulli; Laura Marconato; Francesca Abramo; Gennaro Ciliberto; Armin Lahm; Nicola La Monica; Emanuele de Rinaldis
Journal:  BMC Genomics       Date:  2009-03-27       Impact factor: 3.969

Review 10.  The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.

Authors:  Ira Gordon; Melissa Paoloni; Christina Mazcko; Chand Khanna
Journal:  PLoS Med       Date:  2009-10-13       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.